In continuation of Company Announcement no. 8 of 2 June 2017, it is hereby confirmed that approval from the relevant regulatory authorities has been obtained, and that all formal requirements for BioMar’s acquisition of 70% of the Ecuadorian shrimp feed manufacturer Alimentsa now have been fulfilled. Following this, the transaction has been finally effected as at 13 September 2017.
In connection with the acquisition a purchase price allocation will be prepared, where the difference between purchase price and booked equity will be allocated to assets and liabilities resulting in regulations and higher depreciations, effecting EBIT. In 2017 the effect on EBIT is expected to be about DKK 8 million, and in the next 10 years the effect is expected to be about DKK 28 million, after which the effect will decline. Alimentsa submits their accounts in USD which is the local currency in Ecuador.
Regarding the 2017 recognised period, Alimentsa is expected to contribute with revenue of about DKK 150 million and an EBIT of about DKK 20 million to the group financial statement, calculated after purchase price allocation and transaction costs of DKK 8 million.
Aktieselskabet Schouw & Co.
Jørn Ankær Thomsen, Chairman
Jens Bjerg Sørensen, President, tel. +45 8611 2222
Latest posts by Nasdaq NewsFeed (see all)
- Nasdaq Corporate Solutions and Computershare to Simplify Access to Beneficial Shareholder Data for Corporate Issuers in Australia and New Zealand - September 24, 2017
- Gainey McKenna & Egleston Announces VimpelCom, Ltd. Class Action Litigation Update (Now Known As VEON Ltd.) (VEON) - September 24, 2017
- iLOOKABOUT Launches New Mobile Appraiser Product at IAAO Conference - September 24, 2017